Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Occurrence of the parasitic copepod Ergasilus labracis on Threespine Sticklebacks from the south coast of Newfoundland.

Eaves AA, Ang KP, Murray HM.

J Aquat Anim Health. 2014 Dec;26(4):233-42. doi: 10.1080/08997659.2014.938871.

PMID:
25321153
2.

Long-term deregulated human hematopoiesis in goats transplanted in utero with BCR-ABL-transduced lin(-)CD34(+) cord blood cells.

Zeng F, Huang SZ, Gong ZJ, Chen MJ, Baldwin DA, Hu W, Qian H, Yan JB, Wang J, Xiao YP, Chalandon Y, Ringrose A, Ren ZR, Eaves A, Eaves C, Jiang X.

Cell Res. 2013 Jun;23(6):859-62. doi: 10.1038/cr.2013.60. Epub 2013 Apr 30. No abstract available.

3.

Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex.

Chen M, Gallipoli P, DeGeer D, Sloma I, Forrest DL, Chan M, Lai D, Jorgensen H, Ringrose A, Wang HM, Lambie K, Nakamoto H, Saw KM, Turhan A, Arlinghaus R, Paul J, Stobo J, Barnett MJ, Eaves A, Eaves CJ, Holyoake TL, Jiang X.

J Natl Cancer Inst. 2013 Mar 20;105(6):405-23. doi: 10.1093/jnci/djt006. Epub 2013 Feb 27.

4.

Use of Atlantic salmon, Salmo salar L., farm treatment data and bioassays to assess for resistance of sea lice, Lepeophtheirus salmonis, to emamectin benzoate (SLICE(®) ) in British Columbia, Canada.

Saksida SM, Morrison D, McKenzie P, Milligan B, Downey E, Boyce B, Eaves A.

J Fish Dis. 2013 May;36(5):515-20. doi: 10.1111/jfd.12018. Epub 2012 Oct 29. No abstract available.

PMID:
23106395
5.

Substrate utilization during submaximal exercise in children with a severely obese parent.

Eaves AD, Colon A, Dubose KD, Collier D, Houmard JA.

Nutr Metab (Lond). 2012 May 9;9(1):38. doi: 10.1186/1743-7075-9-38.

6.
7.

Effects of griseofulvin on apoptosis through caspase-3- and caspase-9-dependent pathways in K562 leukemia cells: An in vitro study.

Zhong N, Chen H, Zhao Q, Wang H, Yu X, Eaves AM, Sheng W, Miao J, Cui F, Wang J.

Curr Ther Res Clin Exp. 2010 Dec;71(6):384-97. doi: 10.1016/S0011-393X(10)80004-9.

8.

Insights into the stem cells of chronic myeloid leukemia.

Sloma I, Jiang X, Eaves AC, Eaves CJ.

Leukemia. 2010 Nov;24(11):1823-33. doi: 10.1038/leu.2010.159. Epub 2010 Sep 23. Review.

PMID:
20861912
9.

Recent salmon declines: a result of lost feeding opportunities due to bad timing?

Chittenden CM, Jensen JL, Ewart D, Anderson S, Balfry S, Downey E, Eaves A, Saksida S, Smith B, Vincent S, Welch D, McKinley RS.

PLoS One. 2010 Aug 27;5(8):e12423. doi: 10.1371/journal.pone.0012423.

10.

Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate.

Jiang X, Forrest D, Nicolini F, Turhan A, Guilhot J, Yip C, Holyoake T, Jorgensen H, Lambie K, Saw KM, Pang E, Vukovic R, Lehn P, Ringrose A, Yu M, Brinkman RR, Smith C, Eaves A, Eaves C.

Blood. 2010 Sep 23;116(12):2112-21. doi: 10.1182/blood-2009-05-222471. Epub 2010 Jun 23.

11.

Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.

Vercauteren SM, Bashashati A, Wu D, Brinkman RR, Eaves C, Eaves A, Karsan A.

Leuk Res. 2009 Dec;33(12):1636-42. doi: 10.1016/j.leukres.2009.03.019. Epub 2009 May 2.

PMID:
19414193
12.

High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival.

Starczynowski DT, Vercauteren S, Telenius A, Sung S, Tohyama K, Brooks-Wilson A, Spinelli JJ, Eaves CJ, Eaves AC, Horsman DE, Lam WL, Karsan A.

Blood. 2008 Oct 15;112(8):3412-24. doi: 10.1182/blood-2007-11-122028. Epub 2008 Jul 28.

PMID:
18663149
13.

Stem cell biomarkers in chronic myeloid leukemia.

Jiang X, Zhao Y, Forrest D, Smith C, Eaves A, Eaves C.

Dis Markers. 2008;24(4-5):201-16. Review.

14.

Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay.

Louis SA, Rietze RL, Deleyrolle L, Wagey RE, Thomas TE, Eaves AC, Reynolds BA.

Stem Cells. 2008 Apr;26(4):988-96. doi: 10.1634/stemcells.2007-0867. Epub 2008 Jan 24.

15.

Toxicity testing using hematopoietic stem cell assays.

Clarke E, Pereira C, Chaney R, Woodside S, Eaves AC, Damen J.

Regen Med. 2007 Nov;2(6):947-56. Review.

PMID:
18034632
16.

Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity.

Christ O, Lucke K, Imren S, Leung K, Hamilton M, Eaves A, Smith C, Eaves C.

Haematologica. 2007 Sep;92(9):1165-72. Epub 2007 Aug 1.

17.

Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.

Jiang X, Saw KM, Eaves A, Eaves C.

J Natl Cancer Inst. 2007 May 2;99(9):680-93.

PMID:
17470736
18.

The challenges of targeting chronic myeloid leukemia stem cells.

Jiang X, Smith C, Eaves A, Eaves C.

Clin Lymphoma Myeloma. 2007 Mar;7 Suppl 2:S71-80. Review.

PMID:
17382016
19.

Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies.

Jiang X, Zhao Y, Smith C, Gasparetto M, Turhan A, Eaves A, Eaves C.

Leukemia. 2007 May;21(5):926-35. Epub 2007 Mar 1.

PMID:
17330101
20.

A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.

Yang H, Eaves C, de Lima M, Lee MS, Champlin RE, McMannis JD, Robinson SN, Niu T, Decker WK, Xing D, Ng J, Li S, Yao X, Eaves AC, Jones R, Andersson BS, Shpall EJ.

Bone Marrow Transplant. 2006 Mar;37(6):575-82.

PMID:
16435011
21.
22.

Isolation of subsets of immune cells.

Peters CE, Woodside SM, Eaves AC.

Methods Mol Biol. 2005;302:95-116.

PMID:
15937347
23.

Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.

Eisterer W, Jiang X, Christ O, Glimm H, Lee KH, Pang E, Lambie K, Shaw G, Holyoake TL, Petzer AL, Auewarakul C, Barnett MJ, Eaves CJ, Eaves AC.

Leukemia. 2005 Mar;19(3):435-41.

PMID:
15674418
24.

BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice.

Chalandon Y, Jiang X, Christ O, Loutet S, Thanopoulou E, Eaves A, Eaves C.

Leukemia. 2005 Mar;19(3):442-8.

PMID:
15674417
25.

Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL.

Chalandon Y, Jiang X, Loutet S, Eaves AC, Eaves CJ.

Leukemia. 2004 May;18(5):1006-12.

PMID:
15014528
26.

Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome.

Thanopoulou E, Cashman J, Kakagianne T, Eaves A, Zoumbos N, Eaves C.

Blood. 2004 Jun 1;103(11):4285-93. Epub 2004 Feb 12.

PMID:
14962905
27.

Deregulated expression in Ph+ human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia.

Jiang X, Zhao Y, Chan WY, Vercauteren S, Pang E, Kennedy S, Nicolini F, Eaves A, Eaves C.

Blood. 2004 May 15;103(10):3897-904. Epub 2004 Jan 29.

PMID:
14751929
28.

Identification and isolation of hematopoietic stem cells.

Wognum AW, Eaves AC, Thomas TE.

Arch Med Res. 2003 Nov-Dec;34(6):461-75. Review.

PMID:
14734086
29.

Reproduction: widespread cloning in echinoderm larvae.

Eaves AA, Palmer AR.

Nature. 2003 Sep 11;425(6954):146.

PMID:
12968170
30.

Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia.

Jørgensen HG, Allan EK, Jiang X, Liakopoulou E, Richmond L, Eaves CJ, Eaves AC, Holyoake TL.

Leukemia. 2003 Jul;17(7):1430-2. No abstract available.

PMID:
12835742
31.

Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia.

Jiang X, Stuible M, Chalandon Y, Li A, Chan WY, Eisterer W, Krystal G, Eaves A, Eaves C.

Blood. 2003 Oct 15;102(8):2976-84. Epub 2003 Jun 26.

PMID:
12829595
32.

New models to investigate mechanisms of disease genesis from primitive BCR-ABL(+) hematopoietic cells.

Eaves C, Jiang X, Eisterer W, Chalandon Y, Porada G, Zanjani E, Eaves A.

Ann N Y Acad Sci. 2003 May;996:1-9.

PMID:
12799276
33.

Pressure relieving equipment selection in the community: rising to the challenge.

Scanlon L, Eaves A.

Br J Community Nurs. 2002 Dec:19-24.

PMID:
12514497
34.

CML leukapheresis products can be enriched for CD34+ cells and simultaneously depleted of CD15+ cells using a simple Ab cocktail.

Richmond LJ, Alcorn MJ, Pearson C, Cameron G, Thomas T, Eaves CJ, Eaves AC, Holyoake TL.

Cytotherapy. 2002;4(5):407-13.

PMID:
12473207
36.

Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo.

Jiang X, Ng E, Yip C, Eisterer W, Chalandon Y, Stuible M, Eaves A, Eaves CJ.

Blood. 2002 Nov 15;100(10):3731-40. Epub 2002 Jul 5.

PMID:
12393460
37.

Cell separation improves the sensitivity of detecting rare human normal and leukemic hematopoietic cells in vivo in NOD/SCID mice.

Holyoake TL, Horrocks C, Thomas T, Eaves CJ, Eaves AC.

Cytotherapy. 2000;2(6):411-21.

PMID:
12044221
38.

Modulation of p210(BCR-ABL) activity in transduced primary human hematopoietic cells controls lineage programming.

Chalandon Y, Jiang X, Hazlewood G, Loutet S, Conneally E, Eaves A, Eaves C.

Blood. 2002 May 1;99(9):3197-204.

PMID:
11964283
39.

Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia.

Holyoake TL, Jiang X, Drummond MW, Eaves AC, Eaves CJ.

Leukemia. 2002 Apr;16(4):549-58. Review.

40.
41.

Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype.

Uchida N, Fujisaki T, Eaves AC, Eaves CJ.

J Clin Invest. 2001 Oct;108(7):1071-7.

42.

Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders.

Brümmendorf TH, Rufer N, Holyoake TL, Maciejewski J, Barnett MJ, Eaves CJ, Eaves AC, Young N, Lansdorp PM.

Ann N Y Acad Sci. 2001 Jun;938:293-303; discussion 303-4.

PMID:
11458518
43.
44.

Differences between normal and CML stem cells: potential targets for clinical exploitation.

Eaves AC, Barnett MJ, Ponchio L, Cashman JD, Petzer AL, Eaves CJ.

Stem Cells. 1998;16 Suppl 1:77-83; discussion 89. Review.

45.

Autonomous multi-lineage differentiation in vitro of primitive CD34+ cells from patients with chronic myeloid leukemia.

Jiang X, Fujisaki T, Nicolini F, Berger M, Holyoake T, Eisterer W, Eaves C, Eaves A.

Leukemia. 2000 Jun;14(6):1112-21.

46.

Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.

Hogge DE, Lambie K, Sutherland HJ, Benny WB, Dalal B, Currie C, Barnett MJ, Eaves AC, Eaves CJ.

Bone Marrow Transplant. 2000 Mar;25(6):589-98.

47.

Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.

Brümmendorf TH, Holyoake TL, Rufer N, Barnett MJ, Schulzer M, Eaves CJ, Eaves AC, Lansdorp PM.

Blood. 2000 Mar 15;95(6):1883-90.

PMID:
10706851
48.
49.

Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

Jiang X, Lopez A, Holyoake T, Eaves A, Eaves C.

Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12804-9.

50.

Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.

Holyoake T, Jiang X, Eaves C, Eaves A.

Blood. 1999 Sep 15;94(6):2056-64.

PMID:
10477735

Supplemental Content

Support Center